U.S. House Democrats and Republicans “Deeply Concerned” About 340B Rebate Model

Six U.S. House members—three Democrats and three Republicans—are asking House colleagues to sign a letter to U.S. Health and Human Services (HHS) Secretary Alex Azar expressing deep concern about drug industry technology services company Kalderos’ work with drug manufacturers to reconfigure the 340B drug pricing program “from one of up-front discounts to post-sale rebates.” The lawmakers—Reps. Abigail D. Spanberger (D-Va.), Cindy Axne (D-Iowa), David McKinley (R-W.Va.), Dusty Johnson (R-S.D.), John Katko (R-N.Y.), and Doris Matsui (D-Calif.)—set a Friday deadline for signatures.

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.
« Read Previous Read Next »
Generic selectors
Exact matches only
Search in title
Search in content

*Sign up for news summaries and alerts from 340B Report